The Agency for Healthcare Research and Quality (AHRQ) Effective Health Care (EHC) Program is pleased to announce that the following articles are available through the EHC Program Web site:

EHC Program Sponsored Journal Supplement

Pharmacoepidemiology and Drug Safety has just published the proceedings from the 2011 EHC symposium on methods for developing and analyzing clinically rich data for patient-centered outcomes research. To view these articles on the Pharmacoepidemiology and Drug Safety Web site, please visit: http://onlinelibrary.wiley.com/doi/10.1002/pds.v21.S2/issuetoc.

To view a summary of the Symposium on the EHC web site, please visit:  http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=1050.

Pharmacoepidemiology and Drug Safety, Volume 21, Supplement 2, June 2012.

• Methods for Developing and Analyzing Clinically Rich Data for Patient-Centered Outcomes Research: An Overview.
• When to Randomize, or ‘Evidence-Based Medicine Needs Medicine-Based Evidence.
• Analyzing Partially Missing Confounder Information in Comparative Effectiveness and Safety Research of Therapeutics.
• Identification of Metastatic Cancer in Claims Data.
• Linkage of Routinely Collected Oncology Clinical Data with Health Insurance Claims Data—an Example with Aromatase Inhibitors, Tamoxifen, and All-Cause Mortality.
• Merging of the National Cancer Institute–Funded Cooperative Oncology Group Data with an Administrative Data Source to Develop a More Effective Platform for Clinical Trial Analysis and Comparative Effectiveness Research: A Report from the Children’s Oncology Group.
• Incorporating Initial Treatments Improves Performance of a Mortality Prediction Model for Patients with Sepsis.
• Evaluation of Total Hip Arthroplasty Devices Using a Total Joint Replacement Registry.
• Prior Event Rate Ratio Adjustment: Numerical Studies of a Statistical Method to Address Unrecognized Confounding in Observational Studies.
• One-to-Many Propensity Score Matching in Cohort Studies.
• Performance of Propensity Score Methods When Comparison Groups Originate from Different Data Sources.
• Confronting “Confounding by Health System Use” in Medicare Part D: Comparative Effectiveness of Propensity Score Approaches to Confounding Adjustment.
• Dynamic Marginal Structural Modeling to Evaluate the Comparative Effectiveness of More or Less Aggressive Treatment Intensification Strategies in Adults with Type 2 Diabetes.
• Simulation Study of Instrumental Variable Aproaches with an Application to a Study of the Antidiabetic Effect of Bezafibrate.
• Assessing the Applicability of Trial Evidence to a Target Sample in the Presence of Heterogeneity of Treatment Effect.
• Comparative Effectiveness Research Using Matching-Adjusted Indirect Comparison:
  an Application to Treatment with Guanfacine Extended Release or Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder.
• Role of Disease Risk Scores in Comparative Effectiveness Research with Emerging Therapies.
• Reweighted Mahalanobis Distance Matching for Cluster-Randomized Trials with Missing Data.

Thank you, 

Effective Health Care Program
www.effectivehealthcare.ahrq.gov 

If you have any questions or problems with the subscription service, E-mail: [log in to unmask]. For other inquiries, Contact Us.

Update your subscriptions, modify your password or E-mail address, or stop subscriptions at any time on your Subscriber Preferences Page.

This service is provided to you at no charge by the Agency for Healthcare Research and Quality (AHRQ).